Cargando…
Pharmacological inhibition of syntenin PDZ2 domain impairs breast cancer cell activities and exosome loading with syndecan and EpCAM cargo
Exosomes support cell‐to‐cell communication in physiology and disease, including cancer. We currently lack tools, such as small chemicals, capable of modifying exosome composition and activity in a specific manner. Building on our previous understanding of how syntenin, and its PDZ partner syndecan...
Autores principales: | Leblanc, R., Kashyap, R., Barral, K., Egea‐Jimenez, A.L., Kovalskyy, D., Feracci, M., Garcia, M., Derviaux, C., Betzi, S., Ghossoub, R., Platonov, M., Roche, P., Morelli, X., Hoffer, L., Zimmermann, Pascale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737769/ https://www.ncbi.nlm.nih.gov/pubmed/33343836 http://dx.doi.org/10.1002/jev2.12039 |
Ejemplares similares
-
Proteomic peptide phage display uncovers novel interactions of the PDZ1‐2 supramodule of syntenin
por: Garrido‐Urbani, Sarah, et al.
Publicado: (2016) -
Frizzled 7 and PIP(2) binding by syntenin PDZ2 domain supports Frizzled 7 trafficking and signalling
por: Egea-Jimenez, Antonio Luis, et al.
Publicado: (2016) -
Heparanase activates the syndecan-syntenin-ALIX exosome pathway
por: Roucourt, Bart, et al.
Publicado: (2015) -
Syntenin: PDZ Protein Regulating Signaling Pathways and Cellular Functions
por: Shimada, Tadayuki, et al.
Publicado: (2019) -
The PDZ-adaptor protein syntenin-1 regulates HIV-1 entry
por: Gordón-Alonso, Mónica, et al.
Publicado: (2012)